WAVEMAN · COMPANY

ELMD · Electromed, Inc.

LIVE

TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

ELMD

Name: Electromed, Inc. (ELMD) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

Electromed, Inc.

MEDICAL DEVICES · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · CIK 0001488917

SEC FILINGS☆ WATCH

INSIDER NET · 180D

-$2.2M

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

+15.3%

XBRL, annual

NET MARGIN

15.3%

CONVERSIONS · 180D

codes C/M, not in net · $421.0K priced

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net -$2.2M over 180 days

-$354.1K over 90 days

below 66% of Medical Devices

CONGRESS

no member of Congress has reported trading it

FUNDS

77 funds added or opened last quarter

more than 51% of Medical Devices

REVENUE

+15.3% year over year

more than 66% of Medical Devices

MARGIN

15.3% net margin

more than 88% of Medical Devices

BUYBACKS

$3.9M repurchased, FY to 2026-06-30

below 75% of Medical Devices

SHORT

2.1% of shares outstanding short · 1.8 days to cover · settled 2026-07-31

below 60% of Medical Devices

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

Insiders are net sellers: -$2.2M across 3 people in 180 days.

77 funds added or opened positions in the latest 13F quarter, of 131 holders.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +15.3%

+15.3%12M

INSIDER SELL

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

The complete filing record, in one place.

The record shows a net $2.2M sold by insiders over 180 days, 77 funds added last quarter. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

TMO PEN ROK BLFS MTD SIBN WRBY ISRG TXG DXCM EW TMDX

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Electromed, Inc. insiders sold a net $2.2M of stock across 48 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

Cunniff James L.

CEO and President

SELL

2026-06-08

7,003.0

$253.9K

Cunniff James L.

CEO and President

SELL

2026-06-08

1,671.0

$61.5K

Cunniff James L.

CEO and President

SELL

2026-06-08

1,026.0

$38.8K

Nagel Bradley M.

Chief Financial Officer

SELL

2026-06-04

181.0

$6.7K

Nagel Bradley M.

Chief Financial Officer

SELL

2026-06-04

11,620.0

$422.3K

48 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 43 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

J.E. Simmons & Co., P.C.

483,822.0 sh

$20.5M

BlackRock, Inc.

465,619.0 sh

$19.7M

VANGUARD CAPITAL MANAGEMENT LLC

283,232.0 sh

$12.0M

PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.

218,520.0 sh

$9.2M

GEODE CAPITAL MANAGEMENT, LLC

217,115.0 sh

$9.2M

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

Ultra-Small Company Fund

$1.1M POSITION · AS OF 2026-03-31

1.2%

Gabelli Global Mini Mites Fund

$192.0K POSITION · AS OF 2026-03-31

0.9%

ACUITAS US MICROCAP FUND

$403.7K POSITION · AS OF 2026-03-31

0.4%

Ultra-Small Company Market Fund

$416.7K POSITION · AS OF 2026-03-31

0.3%

Invesco Dorsey Wright SmallCap Momentum ETF

$1.1M POSITION · AS OF 2026-02-28

0.3%

Hartford Multifactor Small Cap ETF

$157.2K POSITION · AS OF 2026-04-30

0.3%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Clinical pipeline

ClinicalTrials.gov · 1 registered trials, 0 still enrolling or running — a status change here is dated weeks before the press release

Not applicable

0 ACTIVE

TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED

Executive pay vs shareholder return

DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself

CEO TOTAL

ACTUALLY PAID

OTHER NEOs AVG

TSR

PEER TSR

2024

$1.5M

$4.9M

$756.7K

+128%

—

TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2026-06	2025-06	2024-06	2023-06
REVENUE	$73.8M	$64.0M	$54.7M	$48.1M
GROSS PROFIT	$57.9M	$50.0M	$41.7M	$36.5M
OPERATING INCOME	$13.9M	$9.7M	$6.6M	$4.0M
NET INCOME	$11.3M	$7.5M	$5.2M	$3.2M
EPS (DILUTED)	1.30	0.85	0.58	0.36
OPERATING CASH FLOW	$9.7M	$11.4M	$9.1M	$1.3M
CASH	$20.4M	$15.3M	$16.1M	$7.4M
BUYBACKS	$3.9M	$10.0M	$275.0K	$153.0K

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE